We have located links that may give you full text access.
The influence of methotrexate on hair loss while using immunomodulatory doses.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego 2019 Februrary 29
Hair loss is a significant and constantly growing social problem among both women and men. Many drugs through their toxic effects on the cells of the hair follicle matrix have an influence on mitotic divisions and the hair growth cycle, leading to anagen or telogen effluvium. Currently, there are more and more publications and clinical studies evaluating the possibility of using methotrexate in the treatment of various types of non-scarring and scarring alopecia, but there is no study of the effect relating to the hair loss with low doses of the drug in other therapeutic indications.
AIM: The aim of the study was to evaluate if methotrexate used in immunomodulatory doses could cause increased hair loss.
MATERIALS AND METHODS: Data from a survey was analyzed in 68 patients treated with methotrexate at the Department of Dermatology of the Jagiellonian University in Cracow in the years 2015-2018.
RESULTS: Increased hair loss after the beginning of methotrexate administration occurred in 29,4% of the subjects, the majority (60%) were women. More frequent occurrence of general symptoms was perceived among the patients who reported alopecia.
CONCLUSIONS: Studied group of patients was relatively small, however, it seems that drug hair loss during methotrexate treatment occurs relatively often.
AIM: The aim of the study was to evaluate if methotrexate used in immunomodulatory doses could cause increased hair loss.
MATERIALS AND METHODS: Data from a survey was analyzed in 68 patients treated with methotrexate at the Department of Dermatology of the Jagiellonian University in Cracow in the years 2015-2018.
RESULTS: Increased hair loss after the beginning of methotrexate administration occurred in 29,4% of the subjects, the majority (60%) were women. More frequent occurrence of general symptoms was perceived among the patients who reported alopecia.
CONCLUSIONS: Studied group of patients was relatively small, however, it seems that drug hair loss during methotrexate treatment occurs relatively often.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app